|
Octodrine
|
|
| Systematic (IUPAC) name | |
| 6-methylheptan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | none |
| PubChem | |
| Chemical data | |
| Formula | C8H19N |
| Mol. mass | 129.24 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Octodrine is a stimulant drug whose pharmacology was briefly studied in the early 1950s.[1] A platinum complex form of the molecule was also investigated as a possible anti-tumor drug.[2]
References
- ^ F SEMENZA. Contribution to the pharmacological study of 2-methyl-6-aminoheptane. Bollettino della Società italiana di biologia sperimentale. 1951 Mar;27(3 bis):354-7
- ^ Craciunescu DG, Doadrio A, Furlani A, Scarcia V. Structure-antitumour activity relationships for new platinum complexes. Chem Biol Interact. 1982 Nov;42(2):153-64.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)




